You are here

Approvals, Launches, and New Indications

Easier-to-clean Pentax device may help limit bacterial infections
First once-daily, single-inhaler triple therapy for the disease in the U.S.
Proprietary delivery system deposits proven steroid deep into the nose
Single-dose oral therapy treats leading gynecological infection
Injection is also approved for GEP-NETs
Approval based on totality of evidence from global development program showing Mvasi is highly similar to Genentech’s Avastin
In a clinical trial, the prescription-only adjunct treatment significantly increased patient adherence to abstinence
Options limited for patients, whose disease often returns
Vaccine protects against two A strain and two B strain viruses